ENTITY
Akeso

Akeso (9926 HK)

367
Analysis
Health Care • China
Akeso is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative antibody drugs. It develops treatments for major diseases such as cancer, autoimmune diseases, inflammation, and metabolic diseases, with key products including cadonilimab, ivonescimab, and penpulimab. The company was founded in 2012 and is headquartered in Zhongshan, Guangdong, China.
more
Company Event • 25 Mar 2027 22:30 • Upcoming
Add To Calendar

H2 2026

Company Event • 27 Aug 2026 22:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 29 Mar 2026 16:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 26 Aug 2025 12:30 • Upcoming
Add To Calendar

H1 2025

Company Event • 30 Mar 2025 16:00 • Latest

H2 2024

x